Tuesday 22 December 2015, Amsterdam
The report, now available on ASDReports, "Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Modality (Veno -Arterial (VA), Veno -Venous (VV), Arterio-Venous (AV)), by Application (Respiratory, Cardiac, ECPR), by Geography - Global Forecast to 2020", The global extracorporeal membrane oxygenation (ECMO) system report defines and segments the extracorporeal membrane oxygenation (ECMO) system market globally with analysis and forecast of revenue. This market was valued at USD 227.7 Million in 2014, and is expected to reach USD 287.6 Million by 2020, at a CAGR of 4.0% from 2015 to 2020.
The global extracorporeal membrane oxygenation (ECMO) system market is expected to witness substantial growth due to number of surgeries, technological advances, physician’s awareness and patient’s safety.
The global extracorporeal membrane oxygenation (ECMO) system market growth is attributed to the rise in the number of patients suffering from respiratory failure and cardiopulmonary disease, and rising incidence in Chronic Obtrusive Pulmonary Diseases (COPD). Despite this, high cost of devices, risk of complication during ECMO treatment, and presence of conventional techniques are some of the hindering factors.
The ECMO system is a device which is a combination of one membrane oxygenator, cannula, oxygen blender, heat exchanger, post membrane pressure monitor, venous reservoir and centrifugal pump. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.
In 2014, the global extracorporeal membrane oxygenation (ECMO) system market was dominated by North America. This market is segmented and forecast on the basis of modality, application and geography. The modality comprises of Veno Artrial (VA), Veno Venous (VV), Artrio Venous (ECOO2 R). On the basis of application, the market is segmented into respiratory, cardiac, and Extra-Corporeal Cardiopulmonary Resuscitation (ECPR). The market is further segmented and forecast on the basis of major geographies such as North America, Europe, Asia-pacific and rest of the world (RoW).
The market in North America is growing due to improved patient safety and awareness among the doctors and patients for low flow aesthetic agents. The European market is growing due to the technological advancements and is dominated majorly by MAQUET Holding B.V. & CO. KG. (Germany). The Asian market is growing due to increasing adoption rate of ECMO machine in hospitals, success rate of ECMO & government initiatives, and growing awareness towards ECMO.
This report also includes the market share, approach for arriving at the market size, new technology developments, product matrix, life cycle analysis, Porter’s five forces analysis and price analysis by product. In this report, market metrics are also included such as drivers, restraints and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market including major companies which provide extracorporeal membrane oxygenation (ECMO) system as a product.
The research study is aimed at identifying emerging trends and opportunities in the global extracorporeal membrane oxygenation (ECMO) system market along with detailed classifications, in terms of revenue. It provides comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation
ASDReports.com Media contact: S. Koopman -
Marketing and Communications
ASDReports.com / ASDMedia BV - Veemkade 356 - 1019HD Amsterdam - The Netherlands
P : +31(0)20 486 1286 - F : +31(0)20 486 0216 - E : email@example.com
back to News